Healthcare - Biotechnology - NASDAQ - US
$ 0.4751
-3.98 %
$ 4.16 M
Market Cap
-0.02
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
70.38%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Windtree Therapeutics, Inc.
WINT has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart WINT
EBIT FORECAST
EBIT Forecast Chart WINT
NET INCOME FORECAST
Net Income Chart WINT